Stay updated on Ganetespib Combo with Docetaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Ganetespib Combo with Docetaxel in NSCLC Clinical Trial page.

Latest updates to the Ganetespib Combo with Docetaxel in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 in the site footer; removed the previous funding notice and Revision: v3.4.1.SummaryDifference0.1%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding was added and the page revision updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedNew glossary toggle is now visible, and the page displays Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The old items Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a comprehensive Locations section listing study sites across numerous US states and international regions, including Arizona, California, Colorado, and many other locations worldwide.SummaryDifference3%

- Check85 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2. No substantive changes to study details, eligibility criteria, or results.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision: v3.3.1 replaces v3.2.0 on the page; no study content or results were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Ganetespib Combo with Docetaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ganetespib Combo with Docetaxel in NSCLC Clinical Trial page.